Development of Resistance to Ofloxacin G. C. CrumplinM. Odell Section 1: Antibacterial Properties of Ofloxacin 27 November 2012 Pages: 1 - 8
Bactericidal Activity of Ofloxacin versus Roxithromycin in the Treatment of Streptococcus pneumoniae P. M. ShahV. SchäferW. Stille Section 1: Antibacterial Properties of Ofloxacin 27 November 2012 Pages: 9 - 13
Interpretive Criteria for the Agar Diffusion Susceptibility Test with Ofloxacin Heinz Grimm Section 1: Antibacterial Properties of Ofloxacin 27 November 2012 Pages: 14 - 19
General Discussion: Section 1 Section 1: Antibacterial Properties of Ofloxacin 27 November 2012 Pages: 20 - 20
Comparative Pharmacokinetics of New Quinolones H. LodeG. HöffkenP. Koeppe Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 21 - 25
Penetration of Ofloxacin from Blood to Sputum B. I. DaviesF. P. V. MaesenC. Baur Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 26 - 32
Penetration of Ofloxacin into Bronchial Secretions J. SymondsM. BoneA. Javaid Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 33 - 36
Diffusion of Ofloxacin into Human Lung Tissue L. CouraudJ. B. FourtillanM. Vincent du Laurier Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 37 - 38
Biliary Tract Excretion of Ofloxacin in Man Antoine KazmierczakAndré PechinotJean-Pierre Favre Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 39 - 43
In Vitro Activity and Concentrations in Serum, Urine, Prostatic Secretion and Adenoma Tissue of Ofloxacin in Urological Patients K. G. NaberD. AdamF. Kees Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 44 - 50
Pharmacokinetics of Ofloxacin in Healthy Subjects and Patients with Impaired Renal Function D. HöfflerP. Koeppe Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 51 - 55
A Preliminary Report on the Pharmacokinetics of Ofloxacin, Desmethyl Ofloxacin and Ofloxacin N-Oxide in Patients with Chronic Renal Failure L. O. WhiteA. P. MacGowanI. G. Mackay Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 56 - 61
Pharmacokinetics of Ofloxacin in Patients on Haemodialysis Treatment A. Dörfler IIIW. SchulzM. Zichner Section 2: Pharmacokinetic Profile of Oxfloxacin 27 November 2012 Pages: 62 - 70
An Open Randomised Comparison of Ofloxacin and Doxycycline in Lower Respiratory Tract Infections Helmut HarazimJohann WimmerHans P. Mittermayer Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 71 - 73
The Use of Quinolones in Respiratory Tract Infections F. P. V. MaesenB. I. DaviesC. Baur Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 74 - 79
Clinical Efficacy of Ofloxacin in Lower Respiratory Tract Infections C. GrassiG. Gialdroni GrassiP. Mangiarotti Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 80 - 82
Ofloxacin in Respiratory Tract Infection Atsushi SaitoMasataka KatsuRinzo Soejima Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 83 - 89
General Discussion: Section 3 Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 90 - 90
Open Randomised Comparison of Ofloxacin and Norfloxacin in the Treatment of Complicated Urinary Tract Infections Erwin W. Rugendorff Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 91 - 94
Clinical Experience with Ofloxacin in Upper and Lower Urinary Tract Infections G. LudwigH. Pauthner Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 95 - 99
Ofloxacin versus Trimethoprim-Sulphamethoxazole in Acute Cystitis J. M. BlockR. A. WalstadL. -E. Peterson Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 100 - 106
Single Doses of Ofloxacin in Uncomplicated Gonorrhoea J. AznarR. PradosEvelio J. Perea Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 107 - 110
Acute Nongonococcal Epididymitis W. WeidnerH. G. SchieferCh. Garbe Section 4: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 111 - 117
Chairman’s Review K. Moehring Section 3: Ofloxacin in Respiratory Tract Infections 27 November 2012 Pages: 118 - 118
Efficacy and Tolerance of Oral Ofloxacin in Treating Various Infections Helen GiamarellouJohn Tsagarakis Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 119 - 123
Ofloxacin Treatment in the Management of Chronic Osteitis R. KetterlT. BeckurtsB. Claudi Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 124 - 130
Antimicrobial Prophylaxis in Immunocompromised Patients J. H. Hartlapp Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 131 - 133
The Possible Role of Quinolones in Yersiniosis J. A. A. Hoogkamp-Korstanje Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 134 - 138
Chemotherapy of Otitis Media with Ofloxacin T. Lenarz Section 5: Ofloxacin in Other Infections 27 November 2012 Pages: 139 - 143
Side Effects of Ofloxacin in Clinical Trials and in Postmarketing Surveillance Günther JüngstRüdiger Mohr Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 144 - 149
Overview of Toxicological Studies D. G. Mayer Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 150 - 153
Influence of Ofloxacin on the Faecal Flora Tore Midtvedt Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 154 - 158
Steady-State Kinetics of the Quinolone Derivatives Ofloxacin, Enoxadn, Ciprofloxacin and Pefloxacin during Maintenance Treatment with Theophylline W. J. A. WijnandsT. B. VreeC. L. A. van Herwaarden Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 159 - 169
Interaction Between Quinolones and Caffeine A. H. StaibW. StilleC. Beer Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 170 - 174
Chairman’s Review R. Wise Section 6: The Safety Profile of Ofloxacin and Drug Interaction Studies 27 November 2012 Pages: 175 - 175
Present Day Susceptibility of Urinary Pathogens to Antimicrobials M. S. SabbourL. M. OsmanW. F. El-Baz Section 7: Short Communication 27 November 2012 Pages: 176 - 177
Ofloxacin in Cystic Fibrosis H. Meyer Section 7: Short Communication 27 November 2012 Pages: 177 - 179
Ofloxacin in Lower Respiratory Tract Infections Pentti Hänninen Section 7: Short Communication 27 November 2012 Pages: 179 - 180
Activity of Ofloxacin against Chlamydia trachomatis Birger R. MøllerRoger EvansEllis From Section 7: Short Communication 27 November 2012 Pages: 181 - 182
Application of Ofloxacin in Gynaecology Eiko E. PetersenTeresa Sanabria de IseleNorbert Weiss Section 7: Short Communication 27 November 2012 Pages: 183 - 186
Epididymitis H. W. AsbachM. D. Melekos Section 7: Short Communication 27 November 2012 Pages: 186 - 187